Your browser doesn't support javascript.
loading
The first steps towards a diverse and inclusive EBMT: a position paper.
Montoto, S; Snowden, J A; Chabannon, C; Corbacioglu, S; de la Camara, R; Dolstra, H; Greco, R; Gusi, A; Hamad, N; Kenyon, M; Kröger, N; Mohty, M; Murray, J; Mueller, A; Neven, B; Peffault de Latour, R; Peric, Z; Sánchez-Ortega, I; Sureda, A; Verhoeven, B; Villar, A; Yakoub-Agha, I.
Afiliação
  • Montoto S; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK. s.montoto@qmul.ac.uk.
  • Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Chabannon C; Department of Oncology & Metabolism, Medical School, The University of Sheffield, Sheffield, UK.
  • Corbacioglu S; Centre de Thérapie Cellulaire & Inserm CBT-1409, Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer, Marseille, France.
  • de la Camara R; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.
  • Dolstra H; Hospital de la Princesa, Madrid, Spain.
  • Greco R; Department of Laboratory Medicine-Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gusi A; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Hamad N; EBMT Executive Office, Barcelona, Spain.
  • Kenyon M; Department of Haematology, St. Vincent's Hospital Sydney and St. Vincent's Clinical School Sydney, University of New South Wales, Sydney, NSW, Australia.
  • Kröger N; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
  • Mohty M; Department of Stem Cell Transplantation, University Hospital. Hamburg, Hamburg, Germany.
  • Murray J; Service d'Hématologie Clinique et Thérapie Cellulaire, Sorbonne University, Saint Antoine Hospital and INSERM UMRs 938, Paris, France.
  • Mueller A; Haematology and Transplant Unit, Christie Hospital NHS Foundation Trust, Manchester, UK.
  • Neven B; EBMT Executive Office, Barcelona, Spain.
  • Peffault de Latour R; Unité d'immuno-hématologie pédiatrique, Hopital Necker, assistance publique hopitaux de Paris, Institut IMAGINE, Université de Paris, Paris, France.
  • Peric Z; BMT Unit, French Reference for Aplastic Anemia and PNH, Hôpital Saint Louis, Paris, France.
  • Sánchez-Ortega I; University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Sureda A; EBMT Executive Office, Barcelona, Spain.
  • Verhoeven B; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.
  • Villar A; Patient Advocacy Committee, EBMT Executive Office, Barcelona, Spain.
  • Yakoub-Agha I; EBMT Executive Office, Barcelona, Spain.
Bone Marrow Transplant ; 57(3): 343-346, 2022 03.
Article em En | MEDLINE | ID: mdl-35121807

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido